Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Starbucks
SBUX
|
+$382M |
| 2 |
CELG
Celgene Corp
CELG
|
+$329M |
| 3 |
Tesla
TSLA
|
+$261M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$254M |
| 5 |
Intel
INTC
|
+$246M |
Top Sells
| 1 |
Fortive
FTV
|
+$1.15B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$331M |
| 5 |
Amazon
AMZN
|
+$262M |
Sector Composition
| 1 | Technology | 13.89% |
| 2 | Healthcare | 13.88% |
| 3 | Financials | 13.32% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAU
2876
Galiano Gold
GAU
$654M
| $262K | ﹤0.01% |
409,888
+133,005
| +48% | +$85K |
|
2877
S&T Bancorp
STBA
$1.5B
| $262K | ﹤0.01% |
6,931
+2,216
| +47% | +$83.8K |
|
|
LLL
2878
DELISTED
L3 Technologies, Inc.
LLL
| $261K | ﹤0.01% |
1,502
-282,204
| -99% | -$49M |
|
2879
HealthStream
HSTM
$855M
| $260K | ﹤0.01% |
10,750
+2,282
| +27% | +$55.2K |
|
|
PZN
2880
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $259K | ﹤0.01% |
29,980
-21,356
| -42% | -$184K |
|
2881
Skywest
SKYW
$4.35B
| $258K | ﹤0.01% |
5,809
-12,724
| -69% | -$565K |
|
2882
KNOT Offshore Partners
KNOP
$300M
| $257K | ﹤0.01% |
+14,358
| New | +$257K |
|
2883
Sapiens International
SPNS
$2.4B
| $257K | ﹤0.01% |
23,343
-70,865
| -75% | -$780K |
|
2884
West Bancorporation
WTBA
$344M
| $257K | ﹤0.01% |
13,452
-7,445
| -36% | -$142K |
|
2885
TETRA Technologies
TTI
$630M
| $256K | ﹤0.01% |
152,292
-434,711
| -74% | -$731K |
|
2886
Urban One Class D
UONEK
$34.6M
| $256K | ﹤0.01% |
159,008
-39,967
| -20% | -$64.3K |
|
|
MSVB
2887
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
| $256K | ﹤0.01% |
22,104
-9,853
| -31% | -$114K |
|
|
NBEV
2888
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $256K | ﹤0.01% |
+49,248
| New | +$256K |
|
2889
Entegris
ENTG
$13.2B
| $255K | ﹤0.01% |
9,155
-115,471
| -93% | -$3.22M |
|
|
EIGR
2890
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $255K | ﹤0.01% |
+836
| New | +$255K |
|
|
LION
2891
DELISTED
Fidelity Southern Corporation
LION
| $255K | ﹤0.01% |
+9,806
| New | +$255K |
|
2892
Bionano Genomics
BNGO
$18.2M
| $254K | ﹤0.01% |
+81
| New | +$254K |
|
2893
Columbia Financial
CLBK
$1.6B
| $254K | ﹤0.01% |
16,600
+2,023
| +14% | +$31K |
|
2894
Capital Southwest
CSWC
$1.27B
| $254K | ﹤0.01% |
13,209
+2,945
| +29% | +$56.6K |
|
2895
Vanguard Industrials ETF
VIS
$6.13B
| $254K | ﹤0.01% |
+2,107
| New | +$254K |
|
|
Y
2896
DELISTED
Alleghany Corporation
Y
| $254K | ﹤0.01% |
408
-37,525
| -99% | -$23.4M |
|
|
CALA
2897
DELISTED
Calithera Biosciences, Inc
CALA
| $254K | ﹤0.01% |
3,163
+389
| +14% | +$31.2K |
|
2898
Cytokinetics
CYTK
$6.12B
| $251K | ﹤0.01% |
39,704
-189,213
| -83% | -$1.2M |
|
|
PMO
2899
Putnam Municipal Opportunities Trust
PMO
$291M
| $251K | ﹤0.01% |
+22,321
| New | +$251K |
|
2900
XBiotech
XBIT
$83.8M
| $249K | ﹤0.01% |
49,036
-113,392
| -70% | -$576K |
|